Replies to post #706021 on NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

Great points. :)

No two patients are the same. In what you describe it would be IMpossible to conduct medical trials no matter what.

This patient has eaten candy and meat all of his life this patient has a chronic long disorder this patient has a rare DNA deviation this patient is diabetes, this patient has chronic depression, this male patient is 63 years and 8 months etc etc. How for f#c# sake are you going to find 300 placebo patients identical to 300 treatment patients if you morons would write the rules for medical trials?

The FDA had indicated a wish list for ECAs in the Anals article they wrote a few years ago… however, IMO (and I am the last person to be an expert in this, so my opinion isn’t worth too terribly much), obtaining patient level from other biotech and pharmaceutical trials is pretty much impossible, unless you owned the trial data. So good luck with that.